Homa Rahnamoun, PhD
Dana-Farber Cancer Institute
Homa Rahnamoun was born and raised in Tehran, Iran. At age eighteen, she immigrated to the United States and began her higher education journey at a community college before transferring to UC San Diego and pursuing her B.S. in Bioengineering. As an undergraduate student, she conducted research in two labs with focus on systems biology and molecular biosensors. Homa worked as a research associate for two years, prior to joining UC San Diego’s Biological Sciences graduate program in 2016. Her graduate studies that were focused on deregulation of enhancer elements by mutant p53 resulted in three first-author research papers and one review article. In graduate school, she was chosen as an NSF graduate research fellow, recognized as an ARCS scholar, and awarded the founding faculty prize in graduate excellence. Following the completion of her PhD thesis in Summer of 2020, she started her postdoctoral training at Dana Farber Cancer Institute, under the supervision of Dr. Scott Armstrong where she studies the molecular mechanisms that underlie resistance to Menin inhibition in AML.